BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28068824)

  • 1. Three-dimensional power Doppler ultrasound in the early assessment of response to concurrent chemo-radiotherapy for advanced cervical cancer.
    Xu Y; Zhu L; Ru T; Wang H; He J; Zhou Z; Yang X
    Acta Radiol; 2017 Sep; 58(9):1147-1154. PubMed ID: 28068824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility study.
    Xu Y; Zhu L; Liu B; Ru T; Wang H; He J; Liu S; Yang X; Zhou Z; Liu T
    BMC Cancer; 2017 Jun; 17(1):427. PubMed ID: 28629386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional power Doppler ultrasound for the study of cervical cancer and precancerous lesions.
    Belitsos P; Papoutsis D; Rodolakis A; Mesogitis S; Antsaklis A
    Ultrasound Obstet Gynecol; 2012 Nov; 40(5):576-81. PubMed ID: 22323111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
    Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
    Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogram analysis of apparent diffusion coefficient for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
    Meng J; Zhu L; Zhu L; Ge Y; He J; Zhou Z; Yang X
    Acta Radiol; 2017 Nov; 58(11):1400-1408. PubMed ID: 28273745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional power Doppler ultrasound in cervical carcinoma: monitoring treatment response to radiotherapy.
    Huang YF; Cheng YM; Wu YP; Chen HH; Hsu KF; Wu YH; Chou CY
    Ultrasound Obstet Gynecol; 2013 Jul; 42(1):84-92. PubMed ID: 22744872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging.
    Zhu L; Zhu L; Shi H; Wang H; Yan J; Liu B; Chen W; He J; Zhou Z; Yang X; Liu T
    BMC Cancer; 2016 Feb; 16():79. PubMed ID: 26860361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
    Meng J; Zhu L; Zhu L; Wang H; Liu S; Yan J; Liu B; Guan Y; Ge Y; He J; Zhou Z; Yang X
    Radiat Oncol; 2016 Oct; 11(1):141. PubMed ID: 27770816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-Dimensional Power Doppler Ultrasound for Predicting Response and Local Recurrence After Concomitant Chemoradiation Therapy for Locally Advanced Carcinoma of the Cervix.
    Alcazar JL; Arribas S; Martinez-Monge R; Jurado M
    Int J Gynecol Cancer; 2016 Mar; 26(3):534-8. PubMed ID: 26745701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting and Early Monitoring Treatment Efficiency of Cervical Cancer Under Concurrent Chemoradiotherapy by Intravoxel Incoherent Motion Magnetic Resonance Imaging.
    Zhu L; Zhu L; Wang H; Yan J; Liu B; Chen W; He J; Zhou Z; Yang X
    J Comput Assist Tomogr; 2017; 41(3):422-429. PubMed ID: 27824669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional power Doppler imaging of early-stage cervical cancer.
    Hsu KF; Su JM; Huang SC; Cheng YM; Kang CY; Shen MR; Chang FM; Chou CY
    Ultrasound Obstet Gynecol; 2004 Nov; 24(6):664-71. PubMed ID: 15517537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early response of patients undergoing concurrent chemoradiotherapy for cervical cancer: a comparison of PET/CT and MRI.
    Lee JE; Huh SJ; Nam H; Ju SG
    Ann Nucl Med; 2013 Jan; 27(1):37-45. PubMed ID: 23054833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonic histogram assessment of early response to concurrent chemo-radiotherapy in patients with locally advanced cervical cancer: a feasibility study.
    Xu Y; Ru T; Zhu L; Liu B; Wang H; Zhu L; He J; Liu S; Zhou Z; Yang X
    Clin Imaging; 2018; 49():144-149. PubMed ID: 29414509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
    Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to assess residual tumor in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
    Testa AC; Moro F; Pasciuto T; Moruzzi MC; Di Legge A; Fuoco G; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta A; Miccò M; Rufini V; Scambia G; Ferrandina G
    Ultrasound Obstet Gynecol; 2018 Jul; 52(1):110-118. PubMed ID: 29119649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Color Doppler velocimetry and three-dimensional color power angiography of cervical carcinoma.
    Testa AC; Ferrandina G; Distefano M; Fruscella E; Mansueto D; Basso D; Salutari V; Scambia G
    Ultrasound Obstet Gynecol; 2004 Sep; 24(4):445-52. PubMed ID: 15343602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of three-dimensional power Doppler to predict clinical and histological response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.
    Qin J; Cheng X; Chen X; Zhang X; Lu W; Xie X
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):226-34. PubMed ID: 21845741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D vocal power Doppler sonography for the estimation of tumor volume and vascularization in stage IB1 cervical cancer.
    Daskalakis G; Diamantopoulos D; Theodora M; Semertzidou A; Pappa K; Antsaklis P; Sindos M; Rodolakis A; Kalmantis K
    Arch Gynecol Obstet; 2018 Sep; 298(3):617-622. PubMed ID: 30056504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancer.
    Kuang F; Yan Z; Wang J; Rao Z
    Magn Reson Imaging; 2014 May; 32(4):342-9. PubMed ID: 24512795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transvaginal color Doppler sonography for predicting response to concurrent chemoradiotherapy for locally advanced cervical carcinoma.
    Alcázar JL; Castillo G; Martínez-Monge R; Jurado M
    J Clin Ultrasound; 2004; 32(6):267-72. PubMed ID: 15211671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.